Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Pozycja w akcjach
#4690
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Cena akcji
$3.18
Kapitalizacja rynkowa
$3.22B
Zmiana (1 dzień)
0.97%
Zmiana (1 rok)
-13.18%
Kraj
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategoria
Healthcare
Zyski dla Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Zyski w Jun 2026 TTM: $178.32M
Według najnowszych raportów finansowych Jiangsu Nhwa Pharmaceutical Co., Ltd., obecny zysk firmy wynosi $178.32M. W roku 2023 firma osiągnęła zysk w wysokości $165.10M, wzrost w porównaniu do zysku z roku 2022, który wynosił $143.51M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Jiangsu Nhwa Pharmaceutical Co., Ltd. od 2005 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $178.32M | 0.37% |
| 2024 | $177.65M | 7.60% |
| 2023 | $165.10M | 15.04% |
| 2022 | $143.51M | -0.40% |
| 2021 | $144.08M | 10.67% |
| 2020 | $130.19M | 18.18% |
| 2019 | $110.16M | 24.59% |
| 2018 | $88.42M | 29.21% |
| 2017 | $68.43M | 32.53% |
| 2016 | $51.63M | 11.41% |
| 2015 | $46.35M | 10.03% |
| 2014 | $42.12M | 24.43% |
| 2013 | $33.85M | 27.40% |
| 2012 | $26.57M | 38.55% |
| 2011 | $19.18M | 40.39% |
| 2010 | $13.66M | 48.52% |
| 2009 | $9.20M | 26.55% |
| 2008 | $7.27M | 35.65% |
| 2007 | $5.36M | 134.21% |
| 2006 | $2.29M | 10.87% |
| 2005 | $2.06M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 889.56% |
IN
|
